These abnormalities of glucose and lipid metabolism in the Crh−120/+ mice are similar to those reported in the Crh transgenic mouse model, and these include obesity, muscle wasting, hair loss, thin skin, and hypercorticosteronemia (13). This evidence concerns the gene CRH and obesity disorder.